Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
2008
2009
2010
Announcements
Articles
Articles and Publications
Campaign
Case Studies
Charge Capture and Pricing
Coding Integrity
Company
Craneware Insights Articles
Directors
Education
Home
Journey
Opportunities
Other
post
Press Releases
Products
Testimonial
Trade Shows
Uncategorized
Upcoming Events
Webinars
White Papers

Director/PDMR Shareholding and Total Voting Rights

Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 16 March 2018, Craig Preston, CFO of the Company, exercised options over a total of 194,229 ordinary shares of 1p each in the Company (“Ordinary Shares”). In order to fulfil obligations related to the exercise, Mr Preston subsequently sold 112,126 Ordinary Shares at a price of 1,950 pence per share.

Following these transactions, Mr Preston’s shareholding has increased to a total of 82,103 Ordinary Shares, representing 0.3 per cent. of the Company’s issued share capital.

Also on 16 March 2018, certain employees of the Company exercised options over Ordinary Shares. The exercise of these options, as well as the exercise of Mr Preston’s options, were satisfied by the Company’s existing block listing.

Following the exercise of these options described above, the Company’s issued share capital consists of 26,662,271 Ordinary Shares. Accordingly, the figure of 26,662,271 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name:

Craig Preston

 

2

Reason for the notification

 

a)

Position/Status:

 

Chief Financial Officer

b)

Initial Notification/Amendment:

 

Initial Notification

3

Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor

 

a)

Name:

Craneware plc

 

b)

LEI:

213800O2CTJ1YFXNXG05

 

4.

Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

 

a)

Description of the financial instrument:

Identification code:

Ordinary Shares

ISIN GB00B2425G68

 

b)

Nature of the transaction:

 

Exercise of options over Ordinary Shares

 

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£2.08

£3.35

£4.01

£4.00

£3.95

£5.22

72,115

25,099

11,721

16,027

32,459

36,808

d)

Aggregated price(s) and volume(s):

Price(s)

Volume(s)

£3.428

194,229

e)

Date of the Transaction:

 

16 March 2018

f)

Place of the Transaction:

Outside of a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name:

Craig Preston

 

2

Reason for the notification

 

a)

Position/Status:

 

Chief Financial Officer

b)

Initial Notification/Amendment:

 

Initial Notification

3

Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor

 

a)

Name:

Craneware plc

 

b)

LEI:

213800O2CTJ1YFXNXG05

 

4.

Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

 

a)

Description of the financial instrument:

Identification code:

Ordinary Shares

ISIN GB00B2425G68

 

b)

Nature of the transaction:

 

Sale of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£19.50

112,126

d)

Aggregated price(s) and volume(s):

Price(s)

Volume(s)

£19.50

112,126

e)

Date of the Transaction:

 

16 March 2018

f)

Place of the Transaction:

London Stock Exchange

For further information, please contact:

Craneware plc

Peel Hunt

  • +44 (0)20 7418 8900
  • Dan Webster
  • George Sellar
  • Nicole McDougall

Alma

  • +44 (0)208 004 4218
  • Caroline Forde
  • Robyn Fisher
About Craneware

Craneware (AIM: CRW.L) is the market leader in software and supporting services that help healthcare providers improve margins so they can invest in quality patient outcomes. The Company’s flagship solution, Chargemaster Toolkit®, has earned the KLAS No.1 ranking in Revenue Cycle – Chargemaster Management since 2006 and is part of Craneware’s value cycle management suite, which includes patient engagement, charge capture and pricing, claims analysis, revenue recovery and retention, and cost analytics solutions.

Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff.

more at www.craneware.com.